About Grifols

Grifols is a world-leading healthcare company, founded in Barcelona in 1940, and dedicated to improving the health and well-being of people in over 100 countries.  More than 75 years of commitment to patients and health professionals, and to innovation by promoting plasma protein therapies, clinical diagnosis technology and pharmaceutical preparations for hospital use.

With the world’s largest network of plasma donation centers, the Grifols Bioscience Division is a leading producer of plasma medicines for the treatment of rare, chronic, and sometimes life-threatening conditions.  Grifols’ comprehensive process of plasma collection, fractionation, purification, and production, at three state-of-the-art facilities located in Spain and the United States, helps ensure a reliable, consistent source of plasma derived medicines worldwide  to meet the growing demand.